PARIS (Reuters) – France will acquire a stake in sanafi Opella (NASDAQ:) through the Bank of Public Investments (BPI), said Finance Minister Antoine Armand on Sunday, confirming a report from the newspaper Le Figaro according to which the American private equity firm Clayton Dubilier & Rice (CD&R) will acquire a 51% stake. in the company that manufactures one of the best-selling pain relievers in France, Doliprane.
The plan for the Bank of Public Investment (BPI) to acquire a 1% stake in Opella, for about 150 million euros ($162.98 million), arose from a tripartite agreement between Sanofi, the French State and CD&R and It was approved by Sanofi's board of directors on Sunday, the newspaper said.
Finance Minister Antoine Armand had said earlier this week that the government was analyzing all options regarding Opella, including including the state on Opella's board of directors.
(1 dollar = 0.9204 euros)
!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=’2.0′;n.queue=();t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e)(0);s.parentNode.insertBefore(t,s)}(window, document,’script’,’https://connect.facebook.net/en_US/fbevents.js’);
